eli lilly

AntiNarcoleptic Drugs vs Narcolepsy Chronic Sleep disorder.mp4


 

AntiNarcoleptic drugs vs Narcolepsy chronic sleep disorder.mp4 – Narcolepsy is a chronic neurological disorder caused by the brains inability to regulate the correct times for sleeping and the correct times to be awake. At various moments throughout the day, people with narcolepsy experience sudden urges to sleep. If the urge becomes overwhelming, they may do so for periods lasting from a few seconds to several minutes. The condition is profoundly disabling, interrupting lifes basic day to day activities, including working, driving, even conversing with others. Narcolepsy affects about 1 in every 2000 Americans. Narcolepsy is a chronic sleep disorder, or dyssomnia, characterized by excessive daytime sleepiness (EDS) in which a person experiences extreme fatigue and possibly falls asleep at inappropriate times, such as while at work or at school. Narcoleptics usually experience disturbed nocturnal sleep and an abnormal daytime sleep pattern, which is often confused with insomnia. When a narcoleptic falls asleep they generally experience the REM stage of sleep within 10 minutes; whereas most people do not experience REM sleep until after 90 minutes. There is little evidence to suggest that narcoleptics tend to have a shorter life span. Provigil: An oral drug first approved by the FDA in 1998 for the treatment of narcolepsy, a condition in which there is an uncontrollable desire to sleep. Provigil promotes wakefulness. In 2004 the FDA also approved Provigil for the treatment of obstructive sleep apnea and sleeping problems caused by shift

 

Who knew? Patients' share of health spending is shrinking

Filed under: drug addiction treatment act 2000

Such outlays fell to 27.7 percent of the health care economy in 2011, down from 28 percent in 2010 and from 32 percent in 2000, according to the national health expenditures report issued by HHS last week. That's in … "People these days are spending …
Read more on KING5.com

 

Why Dr. Oz's Endorsement Of ChromaDex's Product Is Huge

Filed under: drug addiction treatment act 2000

Certainly, Eli Lilly (LLY) has been riding the wave of investor excitement with its own beta amyloid targeting Alzheimer's treatment. The pharmaceutical … Yet, it has caused Lilly to rise 32% over the last 12 months off, or, nearly 2,000 bps more …
Read more on Trefis

 

Perianal Dermatitis: Much More Than Just a Diaper Rash

Filed under: drug addiction treatment act 2000

The incidence of SPD ranges from about 1 in 2000 to 1 in 200 patient visits.1 However, the most fascinating aspect of these two cases is the very young age of the children, as most series on SPD report a minimum age of 6 to 9 months.1,2 This very …
Read more on Healio